A transrectal ultrasound (TRUS) of the prostate may also be called a prostate sonogram or endorectal ultrasound. A doctor usually performs a TRUS to help diagnose prostate cancer or detect prostate ...
Targeted MRI–transrectal ultrasonography (MRI–TRUS) fusion biopsy is emerging as a powerful new technique to more accurately diagnose clinically significant prostate cancer. A recent study comparing ...
Sextant and extended-sextant biopsy is the mainstay of prostate cancer diagnosis, but might not always sample the primary malignant lesion. Given that misclassification of low-risk disease as a higher ...
March 15, 2012 (Paris, France) — It soon might be possible to detect clinically significant prostate cancer and rule out insignificant prostate cancer using multiparametric (mp) magnetic resonance ...
Does variation in prostate volume calculated with MRI versus TRUS lead to reclassification of men based on current PSA density threshold for active surveillance criteria? Result from a prospective ...
Early diagnosis of prostate cancer, AABH (Aspartyl Asparaginyl β-hydroxylase), a predictive biomarker: A serum immunoassay and personalized medicine. This is an ASCO Meeting Abstract from the 2020 ...
WASHINGTON, D.C.—An imaging technique that combines MRI and transrectal ultrasound (MRI-TRUS) is feasible for performing targeted prostate biopsies. This approach may have some advantages over ...
The global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period. This growth is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results